U6-1241P: A Potential Drug Target and Biomarker for Diseases (G106481572)

Target Name: RNU6-1241P

NCBI ID: G106481572

RNU6-1241P

Other Name(s): RNA, U6 small nuclear 1241, pseudogene

U6-1241P: A Potential Drug Target and Biomarker for Diseases

RNA-U6 small nuclear RNA (snRNA) is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression. One of the well-known RNA molecules derived from U6 snRNA is called U6-1241P. This RNA molecule has been identified as a potential drug target and biomarker for various diseases, including cancer.

The U6-1241P RNA molecule is a single-stranded RNA molecule that contains 124 nucleotides. It is expressed in various tissues and cells of the human body, including the brain, heart, liver, and pancreas. U6-1241P has been shown to play a role in the regulation of gene expression and has been associated with various diseases.

One of the key functions of U6-1241P is its role in the regulation of gene expression. U6-1241P is known to interact with various protein factors, including Ku70 and SnRNA28, to regulate the translation of U6 snRNA into a functional RNA molecule. U6-1241P has also been shown to play a role in the regulation of microRNA (miRNA) expression, which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation.

In addition to its role in gene expression, U6-1241P has also been shown to play a role in the regulation of RNA stability and quality. U6-1241P has been shown to interact with the protein stability-associated RNA (SAI) complex, which is responsible for the stability of various RNA molecules, including U6 snRNA. This interaction between U6-1241P and SAI suggests that U6-1241P may be a potential drug target or biomarker for diseases associated with unstable RNA molecules.

Another function of U6-1241P is its role in the regulation of cellular signaling pathways. U6-1241P has been shown to interact with various signaling proteins, including the protein kinase Akt. This interaction between U6-1241P and Akt suggests that U6-1241P may be a potential drug target or biomarker for diseases associated with altered cellular signaling pathways.

Furthermore, U6-1241P has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration and invasion. U6-1241P has been shown to interact with various proteins involved in these processes, including the protein ZEB2. This interaction between U6-1241P and ZEB2 suggests that U6-1241P may be a potential drug target or biomarker for diseases associated with altered cellular processes.

In conclusion, U6-1241P is a RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its role in the regulation of gene expression, RNA stability and quality, cellular signaling pathways, and cellular processes suggests that U6-1241P may be a valuable tool for the development of new therapeutic strategies for a variety of diseases. Further research is needed to determine the exact role of U6-1241P in disease progression and to identify potential biomarkers for these diseases.

Protein Name: RNA, U6 Small Nuclear 1241, Pseudogene

The "RNU6-1241P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-1241P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets